SCHEMBL21452845

SCHEMBL21452845

COc1cc(-c2cc(N3CCC(C=O)CC3)ncn2)ccc1OC(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 2/20 0.41
▸ PDE3A Q14432 2/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ ITGB2 P05107 7/20 0.40
▸ ICAM1 P05362 7/20 0.40
▸ ITGAL P20701 7/20 0.40
▸ CYP1A2 P05177 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ KMO O15229 1/20 0.38
▸ NEK2 P51955 1/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452765 0.89 ITGB2 (0.40) ITGB2ICAM1ITGALCYP1A2KDM4E
SCHEMBL21433961 0.85 ITGB2 (0.54) PDE3BPDE3APDE10AITGB2ICAM1
SCHEMBL21434142 0.84 TSHR (0.51) PDE3BPDE3APDE10ACYP1A2KDM4E
SCHEMBL21452764 0.78 RPS6KB1 (0.45) ITGB2ICAM1ITGALCYP1A2KDM4E
SCHEMBL21433914 0.75 ITGB2 (0.47) ITGB2ICAM1ITGALKMODPP4
SCHEMBL21434102 0.75 DPP4 (0.48) ITGB2ICAM1ITGALKMODPP4
SCHEMBL21434085 0.75 EPHX2 (0.44) ITGB2ICAM1ITGALKMO
SCHEMBL20782753 0.74 ENPP1 (0.44) ITGB2ICAM1ITGALCYP1A2KDM4E
SCHEMBL21434147 0.73 NPC1 (0.53) ITGB2ICAM1ITGALCYP1A2KDM4E
SCHEMBL21434116 0.73 NPC1 (0.52) ITGB2ICAM1ITGALCYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback